Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Valion Bio (TIVC) Current Taxes (2023 - 2025)

Valion Bio has reported Current Taxes over the past 3 years, most recently at $73000.0 for Q3 2025.

  • For Q3 2025, Current Taxes changed N/A year-over-year to $73000.0; the TTM value through Sep 2025 reached $73000.0, changed N/A, while the annual FY2023 figure was $160000.0, N/A changed from the prior year.
  • Current Taxes for Q3 2025 was $73000.0 at Valion Bio, up from $60000.0 in the prior quarter.
  • Over five years, Current Taxes peaked at $160000.0 in Q4 2023 and troughed at $20000.0 in Q1 2024.
  • A 3-year average of $72600.0 and a median of $60000.0 in 2025 define the central range for Current Taxes.
  • On a YoY basis, Current Taxes climbed as much as 150.0% in 2025 and fell as far as 150.0% in 2025.
  • Year by year, Current Taxes stood at $160000.0 in 2023, then crashed by 87.5% to $20000.0 in 2024, then soared by 265.0% to $73000.0 in 2025.
  • Business Quant data shows Current Taxes for TIVC at $73000.0 in Q3 2025, $60000.0 in Q2 2025, and $50000.0 in Q1 2025.